What is Natural Capsules Ltd (NATCAPSUQ) share price return in the past 10 years?

Natural Capsules Ltd share price has appreciated 6.6% annually (CAGR) over the past ten years.

What is the share price of Natural Capsules Ltd (NATCAPSUQ)?

Company share prices are keep on changing according to the market conditions. The current trading price of Natural Capsules Ltd (NATCAPSUQ) on 09-Jun-2026 16:59:59 at 16:59 is 159.50.

What is the P/E ratio of Natural Capsules?

The latest standalone P/E ratio of Natural Capsules as of 09-Jun-2026 is 14.81.

What is the P/B ratio of Natural Capsules Ltd (NATCAPSUQ)?

The latest standalone P/B ratio of Natural Capsules Ltd (NATCAPSUQ) as of 09-Jun-2026 is 0.92.

What is the 52-week high and low of Natural Capsules Ltd (NATCAPSUQ)?

The 52-week high of Natural Capsules Ltd (NATCAPSUQ) is Rs. 296.40 and the 52-week low is Rs. 137.50.

Natural Capsules Ltd (NATCAPSUQ) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Natural Capsules Ltd (NATCAPSUQ)
Brand: Natural Capsules

Key Metrics

Valuation Multiples

Market Cap

₹166 Cr.

Current Price

₹159.5

52-Week Low / High

₹138 / 296

TTM EPS

₹10.8

TTM Sales

₹174 Cr.

Book Value per Share

₹172.6

P/E Ratio

14.81

Lower than its 5-year historical median

Industry PE

Price to Book (P/B)

0.92

Lower than its 5-year historical median

Price to Sales (P/S)

0.96

Lower than its 5-year historical median

EV/EBITDA

7.66

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

4.51%

Underperforms industry median

Return on Capital Employed (ROCE)

7.41%

Underperforms industry median

Return on Assets (ROA)

2.69%

Operating Profit Margin

11.5%

Net Profit Margin

Gross Profit Margin

10.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

9.19%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

0.16%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

-14.08%

Asset Quality

Promoter Holding

51.04%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹167 Cr.

Equity

₹10.4 Cr.

Face Value

₹10

All Time Low / High

₹0.08 / 679.00

Natural Capsules stock performance

Key Ratios

Check Before You Invest

Quality

Not Good

Check detailed performance

Valuation

Somewhat Undervalued

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is Natural Capsules Ltd a good quality company?

Natural Capsules Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Natural Capsules Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Natural Capsules Ltd vs industry peers?

Natural Capsules Ltd revenue CAGR is 22.23%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Natural Capsules Ltd?

Promoters hold 51.04% of the Natural Capsules Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Natural Capsules Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 6.7% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	11.9%	1.8%	3.6%	4.5%	3.7%	14.6%	22.9%	20.5%	8.4%	7.4%	-
Value Creation Index ⓘ	-0.2	-0.9	-0.7	-0.7	-0.7	0.0	0.6	0.5	-0.4	-0.5	-
Growth Parameters ⓘ
Sales ⓘ	62.1	53.6	54.8	59.8	61.6	79.5	135	173	154	168	174
Sales YoY Gr.	-	-13.6%	2.1%	9.2%	3%	29.2%	69.9%	28%	-11%	9.2%	-
Adj EPS ⓘ	5.8	1.4	1.3	2.3	0.7	7.2	14.7	19.7	7.5	6.4	10.8
YoY Gr.	-	-76.8%	-1.5%	75.2%	-72.1%	1006.2%	104.7%	33.9%	-61.9%	-15.2%	-
BVPS (₹) ⓘ	75.8	71	71.5	73	73.2	81.7	118.5	133.7	141.2	160.4	172.6
Adj Net Profit ⓘ	4.1	1	1	1.8	0.5	5.5	13.8	18.4	7	6.6	11
Cash Flow from Ops. ⓘ	3.5	1.9	5.4	2.1	7.2	5.8	5.1	20.1	5.4	18	-
Debt/CF from Ops. ⓘ	1.6	1.6	0	2.6	0.9	1.7	6.4	2.5	11.5	3.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	11.7%	22.2%	7.5%	9.2%
Adj EPS ⓘ	1%	57.9%	-24.4%	-15.2%
BVPSⓘ	8.7%	17%	10.6%	13.6%
Share Price	6.6%	3.7%	-22.7%	-34.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	8	1.9	1.9	3.2	0.9	9.3	19	17.8	5.5	4.4	6.5
Op. Profit Mgn % ⓘ	15.7	9.6	10.1	8.5	8.9	14.5	18.1	20.1	12.5	11.5	12.3
Net Profit Mgn % ⓘ	6.6	1.9	1.9	3	0.8	6.9	10.2	10.7	4.6	3.9	6.5
Debt to Equity ⓘ	0.1	0.1	0	0.1	0.1	0.2	0.4	0.4	0.5	0.3	0.1
Working Cap Days ⓘ	201	278	273	253	246	231	182	181	239	284	89
Cash Conv. Cycle ⓘ	131	179	172	161	165	97	31	42	83	90	6

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	62	54	55	60	62	80	135	173	154	168
Operating Expenses ⓘ +	52	49	49	55	56	68	111	138	135	149
Manufacturing Costs	13	13	12	15	14	14	22	28	30	31
Material Costs	25	24	24	26	28	37	60	79	77	84
Employee Cost	6	5	5	6	6	7	8	10	11	12
Other Costs ⓘ	9	6	9	8	8	10	21	22	17	21
Operating Profit ⓘ	10	5	6	5	5	11	24	35	19	19
Operating Profit Margin (%)	15.6%	9.6%	10.1%	8.5%	8.8%	14.0%	18.1%	20.1%	12.5%	11.5%
Other Income ⓘ +	1	1	1	1	1	1	2	2	5	4
Exceptional Items ⓘ	0	-1	0	-0	0	2	0	0	0	0
Interest ⓘ	1	1	0	1	1	1	2	4	5	6
Depreciation ⓘ	4	4	4	3	4	4	5	7	9	8
Profit Before Tax ⓘ	6	0	2	2	1	9	19	26	10	9
Tax ⓘ	2	-0	1	0	1	2	5	7	3	3
Profit After Tax	4	1	1	2	1	7	14	19	8	7
PAT Margin (%)	7.0%	1.2%	2.0%	3.2%	1.4%	8.7%	10.3%	11.1%	5.1%	4.0%
Adjusted EPS (₹)	6.1	0.8	1.5	2.5	1.1	9.1	19.9	20.7	8.4	6.5
Dividend Payout Ratio (%)	20%	99.30%	56.10%	32.50%	43.60%	9%	5%	4.80%	0%	0%

Valuation of Natural Capsules - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	54	54	54	55	56	62	83	124	132	166
Share Capital ⓘ	6	6	6	6	6	6	7	9	9	10
Reserves ⓘ	48	48	48	49	49	56	76	115	122	156
Debt +	6	3	0	5	6	10	31	45	56	50
Long Term Debt	0	0	0	0	0	0	15	23	26	20
Short Term Debt	6	3	0	5	6	10	16	22	29	30
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	10	11	12	8	7	16	16	27	30	36
Others Liabilities ⓘ	8	4	5	4	6	9	13	14	14	17
Total Liabilities ⓘ	77	71	71	73	75	97	143	210	231	268
Fixed Assets
Net Fixed Assets ⓘ +	30	26	22	24	24	35	63	93	91	88
Gross Block	61	61	61	66	70	83	108	146	152	158
Accumulated Depreciation	31	35	40	42	46	49	45	53	61	69
CWIP ⓘ	0	0	1	2	2	3	1	0	2	0
Investments ⓘ	5	5	5	5	6	0	0	20	23	23
Inventories	10	8	8	4	5	7	5	8	18	21
Trade Receivables	28	28	31	32	30	27	26	52	54	61
Cash Equivalents	0	0	1	0	1	0	3	2	9	3
Others Assets ⓘ	4	4	3	4	7	25	46	34	36	72
Total Assets ⓘ	77	71	71	73	75	97	143	210	231	268

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	3	2	5	2	7	6	5	20	5	18
PBT ⓘ	6	0	2	2	1	9	19	26	10	9
Adjustment ⓘ	5	4	5	4	5	3	6	10	12	11
Changes in Working Capital ⓘ	-6	-3	-1	-3	1	-4	-16	-10	-15	-0
Tax Paid ⓘ	-2	-0	0	-1	-1	-2	-5	-5	-2	-2
Cash Flow From Investing Activity ⓘ +	-8	-0	-1	-7	-6	-9	-30	-55	-11	-34
Capex	-5	-0	-1	-7	-5	-16	-31	-36	-8	-2
Net Investments	-5	0	0	-0	-1	8	-0	-20	-3	0
Others ⓘ	3	0	0	0	0	0	0	1	-0	-32
Cash Flow From Financing Activity ⓘ +	4	-2	-4	4	-1	3	27	34	7	15
Net Proceeds from Shares ⓘ	3	3	0	0	0	0	8	23	1	28
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	13	8	3	-6
Interest Paid ⓘ	-0	-1	-0	-0	-1	-0	-2	-4	-5	-6
Dividend Paid ⓘ	-1	-1	-1	-1	-1	-0	-1	-1	-1	0
Others ⓘ	2	-3	-3	5	0	3	8	8	9	-1
Net Cash Flow ⓘ	0	0	0	-1	0	-0	1	-1	2	-2

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	8.65	1.17	2.05	3.5	1.54	11.8	19.22	18.54	6.1	4.51
ROCE (%)	11.93	1.77	3.63	4.51	3.71	14.57	22.93	20.5	8.44	7.41
Asset Turnover Ratio	0.95	0.72	0.77	0.83	0.83	0.93	1.12	0.98	0.7	0.67
PAT to CFO Conversion(x)	0.75	2	5	1	7	0.86	0.36	1.05	0.63	2.57
Working Capital Days
Receivable Days	140.30	192.20	197.90	193.70	185.50	131	71.60	82.80	125.40	124.80
Inventory Days	41.20	61	51.90	36.70	28.50	27.30	15.10	13.70	30.70	42
Payable Days	115.40	155.50	173.20	139.90	99.10	112.30	97.70	100.20	134.90	142

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Natural Capsules Ltd FAQs

The current trading price of Natural Capsules on 09-Jun-2026 16:59 is ₹159.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 08-Jun-2026 the market cap of Natural Capsules stood at ₹166.1 Cr

The latest P/E ratio of Natural Capsules as of 08-Jun-2026 is 14.81.

The latest P/B ratio of Natural Capsules as of 08-Jun-2026 is 0.92.

The 52-week high of Natural Capsules is ₹296.4 and the 52-week low is ₹137.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Natural Capsules is ₹174 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Natural Capsules Ltd is a below average quality company.

The key valuation ratios of Natural Capsules Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Natural Capsules Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Natural Capsules Ltd

Natural Capsules (NCL) is a trusted name among capsule manufacturers in India, established in 1993 in Bangalore and expanded in 2003 to Pondicherry. The company operates well-equipped, modern manufacturing facilities for producing hard gelatin capsule shells, hard cellulose (HPMC) capsule shells, and pharmaceutical dosage forms in capsule format. As a WHO-GMP and ISO 9001 certified manufacturer of hard gelatin and HPMC capsules shells, it complies with all national and international standards. The company follows best practices in cGMP (current Good Manufacturing Practice) and cGLP (current Good Laboratory Practice). Since inception, Natural Capsules has provided complete capsule manufacturing solutions, constantly improving through innovation, technology, and product excellence.

The main objective of the company is to manufacture and market Hard Gelatin Capsule shells and Hard Cellulose Capsule Shells (both printed and unprinted). These capsules are sold in domestic and also exported to several countries. The logical integration of NCL hard shell manufacturing to formulation was initiated in the year 1998. The company is also engaged in formulating the pharmaceutical dosage forms in Capsule dosage form, both Pharma and Neutraceutical Products. The Pharmaceutical and Dietary supplement industries count on Natural Capsules to supply hard two-piece Gelatin and Cellulose capsules.

Business Verticals

Capsules Vertical: NCL’s capsules business is anchored in a culture of process innovation, operational excellence, and consistent capital investment. The company’s facilities operate with dedicated manufacturing lines that adhere to globally recognised quality standards, including WHO-GMP, ISO 9001:2015, HACCP, and Halal certifications.

APIs Vertical: In line with its strategic diversification and value-accretive initiatives, NCL entered the Active Pharmaceutical Ingredients (API) segment with the aim of reducing India’s dependence on imports and becoming a key player in niche therapeutic areas. This facility leverages fermentation-based synthesis from Key Starting Materials (KSMs) and is among the few in India to focus on the production of steroidal APIs.

Business area of the company

NCL is a respected manufacturer in the pharmaceutical industry, with a strong presence in both capsule and active pharmaceutical ingredient (API) production.

Products

Hard Gelatin Capsule Shells
Hard Cellulose Capsule Shells
BSE / TSE Free Gelatin Capsule Shells
Shiny Gelatin Capsule Shells
SLS Free Gelatin Capsule Shells
Halal Certified Gelatin Capsule Shells
Fast Release Gelatin Capsule Shells
Printed Gelatin / Cellulose Capsule Shells
Vegetarian Capsule Shells
Enteric Capsule Shells

Milestones

Early Success and Expansion

Natural Capsules Limited was incorporated in 1993 as a Public Limited Company in Bangalore.
Operations commenced in 1995 with three capsule manufacturing lines and an annual capacity of 1.03 billion capsules.
In 2001, the company became the first in India to manufacture vegetarian capsules, marking a significant achievement.
The early 2000s saw rapid expansion, including the acquisition of a Pondicherry unit in 2003.

2005-2007

Acquired five lines from IPCL Godhra and installed them in Pondicherry.

2009-2012

Acquired nine lines from Qualicaps Canada and installed them in Pondicherry.

2011-2014

Upgraded multiple lines, increasing individual capacities from 1 million capsules per day to 1.5 million capsules per day.
By 2014, annual installed capacity had reached 7.1 billion capsules per day

From 2019 onwards

Natural Capsules experienced renewed growth across both domestic and international markets, resulting in improved margins.
The company maintained its emphasis on technological advancement, systematically enhancing its manufacturing capabilities to support increasing demand and operational efficiency.
During this period, a capsule manufacturing line was upgraded to achieve a production rate of 2.5 million capsules per day, up from 1.0 million capsules per day.
The installation of the new generation machine in Bangalore further advanced production, delivering a capacity of 4.8 to 5.0 million capsules per day.
As of the end of FY25, the company’s installed capacity stands at 19.50 billion capsules per annum.
In a significant step, the Company has expanded into active pharmaceutical ingredient (API) manufacturing through its subsidiary, Natural Biogenex.

Natural Capsules Ltd (NATCAPSUQ)

Natural Capsules Ltd (NATCAPSUQ)

Natural Capsules stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Natural Capsules - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Natural Capsules Ltd FAQs

About Natural Capsules Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Natural Capsules Ltd (NATCAPSUQ)

Natural Capsules Ltd (NATCAPSUQ)

Natural Capsules stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Natural Capsules - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Natural Capsules Ltd FAQs

What is the share price of Natural Capsules?

What is the market cap of Natural Capsules?

What is the P/E ratio of Natural Capsules?

What is the P/B ratio of Natural Capsules?

What is the 52-week high and low of Natural Capsules?

What is the TTM revenue of Natural Capsules?

Is Natural Capsules Ltd a good quality company?

Is Natural Capsules Ltd undervalued or overvalued?

Is Natural Capsules Ltd a good buy now?

About Natural Capsules Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.